Nucleophosmin/B26 regulates PTEN through interaction with HAUSP in acute myeloid leukemia

Leukemia

Volumn 27, Issue 5, 2013, Pages 1037-1043

  Noguera, N I ^a,b   Song, M S ^c   Divona, M ^d   Catalano, G ^d   Calvo, K L ^b   Garcia F ^b   Ottone, T ^a,d   Florenzano, F ^a   Faraoni, I ^a,d   Battistini, L ^a   Colombo, E ^e   Amadori, S ^d   Pandolfi, P P ^c   Lo Coco, F ^a,d  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

acute myeloid leukemia; Hausp; PTEN; suppressor gene

Indexed keywords

ENZYME; HERPES VIRUS ASSOCIATED UBIQUITIN SPECIFIC PROTEASE; NUCLEOPHOSMIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER CELL CULTURE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; ENZYME DEGRADATION; GENE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOLECULAR INTERACTION; NPM1 GENE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; UBIQUITINATION;

CELL LINE, TUMOR; HEK293 CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; NUCLEAR PROTEINS; PROTEIN TRANSPORT; PTEN PHOSPHOHYDROLASE; UBIQUITIN THIOLESTERASE; UBIQUITINATION;

EID: 84877594600     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2012.314     Document Type: Article

References (36)

1. Song MS, Salmena L, Pandolfi PP. The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol 2012; 13: 283-296.
2. Chung JH, Eng C. Nuclear-cytoplasmic partitioning of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) differentially regulates the cell cycle and apoptosis. Cancer Res 2005; 65: 8096-8100.
3. Li DM, Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 1997; 57: 2124-2129.
4. Planchon SM, Waite KA, Eng C. The nuclear affairs of PTEN. J Cell Sci 2008; 121: 249-253.
5. Shen WH, Balajee AS, Wang J, Wu H, Eng C, Pandolfi PP et al. Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 2007; 128: 157-170.
6. Hollander MC, Blumenthal GM, Dennis PA. PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nature Rev Cancer 2011; 11: 289-301.
7. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275: 1943-1947.
8. Peterson LM, Kipp BR, Halling Kerr SE, Smith DI, Distad TJ et al. Molecular characterization of endometrial cancer: a correlative study assessing microsatellite instability, MLH1 hypermethylation, DNA mismatch repair protein expression, and PTEN, PIK3CA, KRAS, and BRAF mutation analysis. Int J Gynecol Pathol 2012; 31: 195-205.
9. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997; 15: 356-362.
10. Patel JP, Gönen M, Figueroa ME, Fernandez H, Sun Z, Racevskis J et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med 2012; 366: 1079-1089.
11. Aggerholm A, Groønbaek K, Guldberg P, Hokland P. Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders. Eur J Haematol 2000; 65: 109-113.
12. Liu TC, Lin PM, Chang JG, Lee JP, Chen TP, Lin SF. Mutation analysis of PTEN/ MMAC1 in acute myeloid leukaemia. Am J Hematol 2000; 63: 170-175.
13. Fridberg M, Servin A, Anagnostaki L, Linderoth J, Berglund M, Söderberg O et al. Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the nongerminal center group and poor survival in patients deficient in nuclear PTEN. Leuk Lymphoma 2007; 48: 2221-2232.
14. Yin Y, Shen WH. PTEN: a new guardian of the genome. Oncogene 2008; 27: 5443-5453.
15. Song MS, Salmena L, Carracedo A, Egia A, Lo-Coco F, Teruya-Feldstein J et al. The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature 2008; 455: 813-817.
16. Trotman LC, Wang X, Alimonti A, Chen Z, Teruya-Feldstein J, Yang H et al. Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 2007; 128: 141-156.
17. Mund T, Pelham HR. Regulation of PTEN/Akt and MAP kinase signaling pathways by the ubiquitin ligase activators Ndfip1 and Ndfip2. Proc Natl Acad Sci USA 2010; 107: 11429-11434.
18. Van Themsche C, Leblanc V, Parent S, Asselin E. X-linked inhibitor of apoptosis protein (XIAP) regulates PTEN ubiquitination, content, and compartmentalization. J Biol Chem 2009; 284: 20462-20466.
19. Wang X, Trotman LC, Koppie T, Alimonti A, Chen Z, Gao Z et al. NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN 2007Cell 128: 129-139.
20. Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L et al. GIMEMA Acute Leukemia Working Party. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 2005; 352: 254-266.
21. Falini B, Bolli N, Shan J, Martelli MP, Liso A, Pucciarini A et al. Both carboxyterminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. Blood 2006; 10: 4514-4523.
22. Colombo E, Martinelli P, Zamponi R, Shing DC, Bonetti P, Luzi L et al. Delocalization and destabilization of the Arf tumor suppressor by the leukaemia-associated NPM mutant. Cancer Res 2006; 66: 3044-3050.
23. Grisendi S, Mecucci C, Falini B, Pandolfi PP. Nucleophosmin and cancer. Nat Rev Cancer 2006; 6: 493-505.
24. van Dongen JJ, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 1901-1928.
25. Noguera NI, Ammatuna E, Zangrilli D, Lavorgna S, Divona M, Buccisano F et al. Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia. Leukemia 2005; 19: 1479-1482.
26. Noguera NI, Breccia M, Divona M, Diverio D, Costa V, De Santis S et al. Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol. Leukemia 2002; 16: 2185-2189.
27. Gruszka AM, Lavorgna S, Consalvo MI, Ottone T, Martinelli C, Cinquanta M et al. A monoclonal antibody against mutated nucleophosmin 1 for the molecular diagnosis of acute myeloid leukemias. Blood 2010; 116: 2096-2102.
28. Anderson DH. p85 plays a critical role in controlling flux through the PI3K/PTEN signaling axis through dual regulation of both p110 (PI3K) and PTEN. Cell Cycle 2010; 9: 2055-2056.
29. Chagpar RB, Links PH, Pastor MC, Furber LA, Hawrysh AD, Chamberlain MD et al. Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3- kinase. Proc Natl Acad Sci USA 2010; 107: 5471-5476.
30. Rabinovsky R, Pochanard P, McNear C, Brachmann SM, Duke-Cohan JS, Garraway LA et al. p85 Associates with unphosphorylated PTEN and the PTEN-associated complex. Mol Cell Biol 2009; 29: 5377-5388.
31. Maccario H, Perera NM, Gray A, Downes CP, Leslie NR. Ubiquitination of PTEN. (phosphatase and tensin homolog) inhibits phosphatase activity and is enhanced by membrane targeting and hyperosmotic stress. J Biol Chem2010; 285: 12620-12628.
32. Yilmaz ÖH, Morrison SJ. The PI-3kinase pathway in hematopoietic stem cells and leukaemia-initiating cells: A mechanistic difference between normal and cancer stem cells. Blood Cells Mol Dis 2008; 41: 73-76.
33. Falini B, Martelli MP, Bolli N, Ballanti S, Pettirossi V, Martelli MP. Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity? Blood 2011; 117: 1109-1120.
34. Ferrara F, Izzo T, Criscuolo C, Riccardi C, Muccioli G, Viola A et al. Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfan. Biol Blood Marrow Transplant 2010; 16: 1018-1024.
35. Pasqualucci L, Liso A, Martelli MP, Bolli N, Pacini R, Tabarrini A et al. Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukaemia: Impact on WHO classification 2006. Blood 108: 4146-4155.
36. Leslie NR, Foti M. Non-genomic loss of PTEN function in cancer: not in my genes. Trends Pharmacol Sci 2011; 32: 131-140.